Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 431Terminated 99Recruiting 34Unknown 29Withdrawn 23Active not recruiting 16Suspended 1Not yet recruiting 1No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 15Sarcoma 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 141Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Leukemia 36Leukemia, Lymphocytic, Chronic, B-Cell 34Myelodysplastic Syndromes 24Recurrence 23Lymphoma 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Neoplasms 14Multiple Myeloma 9Motor Activity 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasm, Residual 8Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 8Lymphoma, B-Cell 8Leukemia, B-Cell 8Lymphoma, Mantle-Cell 6Burkitt Lymphoma 6Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Plasma Cell 5Leukemia, Myeloid, Chronic-Phase 5Febrile Neutropenia 5Waldenstrom Macroglobulinemia 4Pain 4Neoplasm Metastasis 4Leukemia, Myelomonocytic, Chronic 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hodgkin Disease × Other hematologic neoplasm × Clear all
NCT06684509 2024-11-12

Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia

Assiut University

Phase 1/2 Not yet recruiting
46 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡